CPIX
Cumberland Pharmaceuticals Inc.
CPIX's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over CPIX overall, supported by lower modeled downside and stronger fundamentals.
CPIX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
CPIX's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CPIX PE Valuation
CPIX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CPIX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
CPIX has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CPIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.73 | -$0.51 |
| Q1 2026 | -$0.49 | -$0.24 |
| Q4 2025 | -$0.19 | +$0.28 |
| Q3 2025 | -$0.24 | +$0.53 |
| Q2 2025 | -$0.22 | +$0.51 |
| Q1 2025 | -$0.25 | +$0.34 |
| Q4 2024 | -$0.47 | -$0.03 |
| Q3 2024 | -$0.77 | -$0.60 |
CPIX lost $0.73 per share over the past year, a bigger loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CPIX on earnings quality, reporting a profit while its opponent remains loss making.
CPIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | -19% |
| Q1 2026 | $9.1M | -22% |
| Q4 2025 | $13.7M | +31% |
| Q3 2025 | $8.3M | -8.7% |
| Q2 2025 | $10.8M | +10% |
| Q1 2025 | $11.7M | +38% |
| Q4 2024 | $10.4M | +12% |
| Q3 2024 | $9.1M | -9.9% |
CPIX's revenue is shrinking: $9M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -36% | -29 points |
| Q1 2026 | -34% | -45 points |
| Q4 2025 | -10% | +7.6 points |
| Q3 2025 | -24% | -5.1 points |
| Q2 2025 | -6.9% | +3.5 points |
| Q1 2025 | 11% | +33 points |
| Q4 2024 | -18% | +48 points |
| Q3 2024 | -19% | -0.1 points |
CPIX's operating margin was −36% last quarter, down 29 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over CPIX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over CPIX on profitability, with a higher operating margin.
CPIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $130.5K | -84% |
| Q1 2026 | $387K | -90% |
| Q4 2025 | $3K | -100% |
| Q3 2025 | $163.4K | -64% |
| Q2 2025 | $817.3K | +$1.7M |
| Q1 2025 | $3.9M | +$6M |
| Q4 2024 | $1.9M | +92% |
| Q3 2024 | $460.1K | -61% |
CPIX still generates free cash flow, though less than at its 2023 peak: $683,899 over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over CPIX on cash flow, with more consistent year-over-year improvement.
CPIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +21.4K shares |
| 1 year | +0.1% | +21K shares |
| 3 years | +2.9% | +427K shares |
| 5 years | -0.8% | -128K shares |
| Available history | -2.5% | -386K shares |
CPIX has 15M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $61,001 |
| Q4 2025 | — |
| Q3 2025 | $10,439 |
| Q2 2025 | $7,171 |
| Q1 2025 | $245,868 |
| Q4 2024 | $98,383 |
| Q3 2024 | $98,815 |
CPIX has spent almost nothing on buybacks in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CPIX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CPIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.6x | Net Cash |
| Q3 2025 | -7.5x | Net Cash |
| Q2 2025 | -6.4x | Net Cash |
| Q1 2025 | -6.5x | Net Cash |
| Q2 2023 | -11.7x | Net Cash |
| Q4 2019 | -12.4x | Net Cash |
CPIX has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CPIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 26.9 | Neutral |
CPIX's weekly RSI is 51 (neutral) and its Stochastic is 27 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CPIX PE vs Healthcare Sector
CPIX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CPIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.78 | 2.2% below |
| 20 week MA | $6.94 | 4.5% below |
| 50 week MA | $5.33 | 24% above |
| 100 week MA | $4.51 | 47% above |
| 200 week MA | $3.12 | 113% above |
CPIX has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 113% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CPIX on trend strength, trading above more of its moving averages.
CPIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.14 | $3.06 | -40% |
| 2021 | $3.06 | $5.12 | +67% |
| 2022 | $5.12 | $2.11 | -59% |
| 2023 | $2.11 | $1.79 | -15% |
| 2024 | $1.79 | $2.32 | +30% |
| 2025 | $2.32 | $4.12 | +78% |
| 2026 YTD | $4.12 | $6.63 | +61% |
CPIX has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.